 The Oncology Report | Drug combo prolongs breast cancer survival time Times of India Everolimus is an established treatment for recurrent, advanced kidney cancer and researchers are now looking at its use in other cancers. The study found that women treated with a combination of everolimus and exemestane had an improved ... Novartis's Afinitor shows promise in breast cancer Afinitor (Everolimus) Prolongs Advanced Breast Cancer Patients' Progression ... Everolimus, exemestane improved outcomes in HT-resistant breast cancer |
